Clinomics IncClinomics Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

If you are employed by Clinomics Inc and you wish to use your ESG rating, please contact us. The page is a free ESG assessment covering Clinomics Inc. This report of Clinomics Inc incorporates data from across the web and also from public documents by Clinomics Inc.

Clinomics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.0; made up of an environmental score of 6.0, social score of 8.0 and governance score of 6.9.

SDG Transparency Score for Clinomics Inc 
Low
0 - 3
Medium
4 - 6

7.0

High Impact
7 - 10
Last Score Update: 2023-07-01
What drives the score for Clinomics Inc 
6.0

Environmental

8.0

Social

6.9

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
326Xencor Inc
7.1
High
326iCo Therapeutics Inc
7.1
High
355Clinomics Inc
7.0
High
355Agile Therapeutics Inc
7.0
High
355Antisense Therapeutics Ltd
7.0
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Clinomics Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Clinomics Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Clinomics Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Clinomics Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Clinomics Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Clinomics Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Clinomics Inc offer flexible work?

LockedSign up for free to unlock

Does Clinomics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Clinomics Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Clinomics Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Clinomics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Does Clinomics Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Clinomics Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Clinomics Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Clinomics Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Clinomics Inc disclose water use targets?

LockedSign up for free to unlock

Does Clinomics Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Clinomics Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Clinomics Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Clinomics Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Clinomics Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Clinomics Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Clinomics Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Clinomics Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Clinomics Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Clinomics Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Clinomics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Clinomics Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is Clinomics Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Clinomics Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Clinomics Inc disclose its waste policy?

LockedSign up for free to unlock

Does Clinomics Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Clinomics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Clinomics Inc disclose energy use targets?

LockedSign up for free to unlock

Does Clinomics Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Clinomics Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Clinomics Inc
These potential risks are based on the size, segment and geographies of the company.

Clinomics Inc., a biotechnology company, provides genome-based cancer and disease diagnostic solutions. It provides TrioDx RT-PCR COVID-19 Test (FDA EUA), liquid biopsy and precision medicines, health care services, and big data solutions. The company's liquid biopsy and precision medicines include CD-PRIME, a platform that offers automated protocols for the enrichment of circulating tumor cells (CTCs), cell free DNA, and EV (exosome) derived from cancer tissues; Cancer-PRIME, a cancer gene analysis service for analyzing results related to precision medicine information with bioinformatics and the detection of various gene mutations; and BioViewCCBS, a scanning platform that helps in capturing cells inside the sample in 3D and in finding and analyzing CTC inside the sample. It also acts as the distributor and seller for AmoyDx's molecule diagnosis method kit in Korea, which is a diagnostics kit used to predict NSCLC patients' reactions to specific drug treatment; for Fluxion Biosciences' Spotlight 59 Panel that provides sensitive detection result with a design for mutated cell detection in cancer samples; and for Fluxion Biosciences' IsoFlux System, an analysis system for circulating tumor cells to extract rare cells to be used in the desired field of applications. In addition, the company provides health care services, such as Geno-P, which provides specialized genome information for 11 physical characteristics based on genome standard reference data; Geno-D that provides prediction services for probability of incidence of diseases; GenomeBook, which provides whole genome information; NIP10, an examination service that is possible after 10 weeks of pregnancy through non-invasive, pre-birth examination to detect fetal chromosome abnormalities; and biological age analysis service. Further, it provides BioComputer, which is an automated computing infrastructure solution to process genomic data. The company was founded in 2011 and is based in Ulsan, South Korea.

Sorry!

Failed to process!